发明名称 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists
摘要 Heterocyclic-substituted tricyclics of the formula or a pharmaceutically acceptable salts thereof, wherein: n<SUB>1 </SUB>and n<SUB>2 </SUB>are independently 0-2; Het is an optionally substituted mono-, bi- or tricyclic heteroaromatic group; B is alkyl or optionally substituted alkenyl; R<SUP>22 </SUP>is -COR<SUP>23 </SUP>or a carboxy, sulfinyl, sulfonyl, sulfonamide or amino acid derivative; R<SUP>23 </SUP>is haloalkyl; alkenyl; haloalkenyl; alkynyl; optionally substituted cycloalkyl; cycloalkyl-alkyl; aryl; arylalkyl; heteroaryl; heterocycloalkyl; or -COOH and/or -SO<SUB>3</SUB>H substituted alkyl; R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>9</SUP>, R<SUP>10 </SUP>and R<SUP>11 </SUP>are as defined in the specification; are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds.
申请公布号 US7037920(B2) 申请公布日期 2006.05.02
申请号 US20020271715 申请日期 2002.10.16
申请人 SCHERING CORPORATION 发明人 CHACKALAMANNIL SAMUEL;CHELLIAH MARIAPPAN V.;CLASBY MARTIN C.;XIA YAN
分类号 A61K31/4355;C07D491/048;A61K31/444;A61P7/02;A61P9/00;A61P9/06;A61P9/10;A61P9/12;A61P11/00;A61P13/12;A61P19/02;A61P29/00;A61P35/00;A61P43/00;C07D491/04;C07D493/04;C07D495/04;C07D515/04 主分类号 A61K31/4355
代理机构 代理人
主权项
地址